These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35978057)

  • 1. Upregulation of KLHL17 promotes the proliferation and migration of non-small cell lung cancer by activating the Ras/MAPK signaling pathway.
    Liu Z; Zhao M; Jiang X; Zhang Y; Zhang S; Xu Y; Ren H; Su H; Wang H; Qiu X
    Lab Invest; 2022 Dec; 102(12):1389-1399. PubMed ID: 35978057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldolase A promotes proliferation and G
    Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
    Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARMC8α promotes proliferation and invasion of non-small cell lung cancer cells by activating the canonical Wnt signaling pathway.
    Xie C; Jiang G; Fan C; Zhang X; Zhang Y; Miao Y; Lin X; Wu J; Wang L; Liu Y; Yu J; Yang L; Zhang D; Xu K; Wang E
    Tumour Biol; 2014 Sep; 35(9):8903-11. PubMed ID: 24894675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway.
    Tang ZP; Dong QZ; Cui QZ; Papavassiliou P; Wang ED; Wang EH
    PLoS One; 2013; 8(6):e63676. PubMed ID: 23776433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
    Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
    Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling.
    Qu L; Tian Y; Wang F; Li Z
    BMC Cancer; 2022 Oct; 22(1):1091. PubMed ID: 36284263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
    Luo F; Zhao Y; Liu J
    Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 11. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
    Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
    J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Expression Promotes Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer via ERK/Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway.
    Liu C; Li H; Jia J; Ruan X; Liu Y; Zhang X
    Med Sci Monit; 2019 Jul; 25():5143-5149. PubMed ID: 31293277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion.
    Hui L; Zhang S; Wudu M; Ren H; Xu Y; Zhang Q; Qiu X
    Thorac Cancer; 2019 Jun; 10(6):1479-1488. PubMed ID: 31124298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway.
    Mi K; Zeng L; Chen Y; Ning J; Zhang S; Zhao P; Yang S
    Cell Signal; 2024 Jan; 113():110962. PubMed ID: 37931691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4.
    Li D; Luo Y; Gao Y; Yang Y; Wang Y; Xu Y; Tan S; Zhang Y; Duan J; Yang Y
    Int J Mol Med; 2016 Sep; 38(3):927-36. PubMed ID: 27431575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
    Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
    Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GRWD1 promotes cell proliferation and migration in non-small cell lung cancer by activating the Notch pathway.
    Wang Q; Ren H; Xu Y; Jiang J; Wudu M; Liu Z; Su H; Jiang X; Zhang Y; Zhang B; Qiu X
    Exp Cell Res; 2020 Feb; 387(2):111806. PubMed ID: 31891681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARHGEF39 promotes tumor progression via activation of Rac1/P38 MAPK/ATF2 signaling and predicts poor prognosis in non-small cell lung cancer patients.
    Zhou H; Cai L; Zhang X; Li A; Miao Y; Li Q; Qiu X; Wang E
    Lab Invest; 2018 May; 98(5):670-681. PubMed ID: 29382922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.